MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-AS-16-0008652
Timsi Pharma India Private Limited
Timsi Pharma India Private Limited - business services in Nagaon, Assam, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹26.66 Lakh
▲ 24% YoY
Net profit · FY 2025
₹59,257
Net margin 2.2%
EBITDA · FY 2025
₹1.03 Lakh
EBITDA margin 3.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Timsi Pharma India Private Limited
Data last updated:
Timsi Pharma India Private Limited is a private limited company based in Nagaon, Assam, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 10 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U74999AS2018PTC018661.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rumi Borah and Kanak Lata Borah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Debendra Nath Borah, Khatar Gaon Nonoi Nagaon, Assam, India – 782101.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.66 Lakh, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹59,257 (net margin 2.2%) and EBITDA of ₹1.03 Lakh (EBITDA margin 3.9%).
Timsi Pharma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-16-0008652). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999AS2018PTC018661
Registration Number 018661
Incorporation Date 10 August 2018
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-AS-16-0008652
Key People
Rumi Borah Director Kanak Lata Borah Director Recognitions & Rankings of Timsi Pharma India
Contact details
Timsi Pharma India Private Limited's registered office is in Nagaon, Assam. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Debendra Nath Borah, Khatar Gaon Nonoi Nagaon, Assam, India – 782101
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Timsi Pharma India Private Limited, buy the company report.
Comprehensive company report
Timsi Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Timsi Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Timsi Pharma India Private Limited, buy the company report.
Financials of Timsi Pharma India Private Limited
FY 2025 filings availableTimsi Pharma India Private Limited reported revenue of ₹26.66 Lakh (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹26.66 Lakh ▲ 24%
Net profit · FY 2025
₹59,257 margin 2.2%
EBITDA · FY 2025
₹1.03 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
EBITDA CAGR growth
1 year
▲ 48%
3 years · compounded
▲ 150%
5 years · compounded
▲ 72%
Revenue rose 24% in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹59,257 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Timsi Pharma India Private Limited, buy the company report.
Board of directors of Timsi Pharma India Private Limited
Timsi Pharma India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rumi Borah Also directs: KRB Foundation | Director | 10 Aug 2018 | 8 Years 3 Months | Current |
| Kanak Lata Borah Also directs: KRB Foundation | Director | 10 Aug 2018 | 8 Years 3 Months | Current |
Peer comparison
Timsi Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Came India Automation Solutions Private Limited | ₹26.68 Lakh (FY 2025) | -90.0% | New Delhi, Delhi, India | |||
| Credence Agricultural Products Private Limited | ₹26.68 Lakh (FY 2025) | 51.0% | Gaya, Bihar, India | |||
| Escogen Lifesciences Private Limited | ₹26.67 Lakh (FY 2025) | 11.0% | Vadodara, Gujarat, India | |||
| Akg Trades Private Limited | ₹26.66 Lakh (FY 2019) | 343.0% | New Delhi, Delhi, India | |||
| Aryadeep Construction Private Limited | ₹26.66 Lakh (FY 2018) | -79.0% | Kolkata, West Bengal, India | |||
| Timsi Pharma India Private Limitedthis company | ₹26.66 Lakh (FY 2025) | ₹59,257 | 2.2% | 24.0% | Nagaon, Assam, India | |
| Metronics Pharma Private Limited | ₹26.65 Lakh (FY 2025) | 161.0% | Pali, Rajasthan, India | |||
| Competent Power Solutions Private Limited | ₹26.65 Lakh (FY 2024) | -76.0% | New Delhi, Delhi, India | |||
| Lumeva Lighting Systems Private Limited | ₹26.65 Lakh (FY 2017) | -27.0% | Pune, Maharashtra, India | |||
| Ankurita Tradefin Pvt Ltd | ₹26.64 Lakh (FY 2024) | 1.0% | Bikaner, Rajasthan, India | |||
| Datacon Systems Pvt Ltd | ₹26.64 Lakh (FY 2025) | 20.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Timsi Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Timsi Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Timsi Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Timsi Pharma India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Timsi Pharma India Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Jogesh Mazumdar ceased to be Director on 01 Sep 2021.
AGM
Timsi Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Timsi Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati.
Ceased
Jogesh Mazumdar ceased to be Director.
Appointed
Kanak Lata Borah was appointed as Director.
Appointed
Rumi Borah was appointed as Director.
Incorporation
10 Aug 2018
Timsi Pharma India Private Limited was registered on 10 Aug 2018 with Roc Guwahati & aged 8 years 3 months as per MCA records.
Frequently asked questions
Timsi Pharma India is an active private limited company based in Nagaon, Assam, India. The company works in other services, within the business services industry. It was incorporated on 10 August 2018 (8+ years old) and is registered under CIN U74999AS2018PTC018661.
Timsi Pharma India has 2 current directors:
- Rumi Borah - Director
- Kanak Lata Borah - Director
The latest financial statements of Timsi Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Timsi Pharma India is U74999AS2018PTC018661. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Timsi Pharma India was incorporated on 10 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Timsi Pharma India by revenue are Came India Automation Solutions Private Limited, Credence Agricultural Products Private Limited, Escogen Lifesciences Private Limited, Akg Trades Private Limited, Aryadeep Construction Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Jogesh Mazumdar ceased to be Director on 01 Sep 2021. Kanak Lata Borah was appointed as Director on 10 Aug 2018. Rumi Borah was appointed as Director on 10 Aug 2018.
Yes, Timsi Pharma India is registered as a micro enterprise under Udyam registration (number: UDYAM-AS-16-0008652).
The registered office of Timsi Pharma India is at CO Debendra Nath Borah, Khatar Gaon Nonoi Nagaon, Assam, India – 782101.
Timsi Pharma India operates in the business services industry, in the other services segment.
The compliance status of Timsi Pharma India is compliant as of 22 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages